Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microglia surveillance is directed toward neuron activation during sustained intracortical microstimulation.

Journal of neural engineering·2026
Same author

Microglia surveillance is directed toward neuron activation during sustained intracortical microstimulation.

bioRxiv : the preprint server for biology·2025
Same author

Polyethylenimine based magnetic nanoparticles mediated non-viral CRISPR/Cas9 system for genome editing.

Scientific reports·2020
Same author

Toward genome editing in X-linked RP-development of a mouse model with specific treatment relevant features.

Translational research : the journal of laboratory and clinical medicine·2018
Same author

Quantification of the vascular endothelial growth factor with a bioluminescence resonance energy transfer (BRET) based single molecule biosensor.

Biosensors & bioelectronics·2016
Same author

Correlation of central visual function and ROP risk factors in prematures with and without acute ROP at the age of 6-13 years: the Giessen long-term ROP study.

The British journal of ophthalmology·2015
Same journal

Corneal Neurotisation in Neurotrophic Keratopathy: A Retrospective Analysis of Functional Outcomes and Clinical Courses.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Evaluating the Long-term Success and Safety of Canaloplasty in Glaucoma Patients.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Imbalanced Trace Elements as Risk Factors in the Pathogenesis of Glaucoma.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Malnutrition as a Risk Factor for Cerebral and Glaucomatous Neurodegeneration - Mechanisms and Therapeutic Strategies.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

Impact of Wearing a Face Mask on the Reliability of Standard Automated Perimetry in Glaucoma Patients and Suspects: a Retrospective Longitudinal Study.

Klinische Monatsblatter fur Augenheilkunde·2026
Same journal

[Siderotic Cataract Eight Months After Intralenticular Metallic Foreign Body: A Case Report and Surgical Management].

Klinische Monatsblatter fur Augenheilkunde·2026
See all related articles

Related Experiment Video

Updated: Mar 8, 2026

Mouse Eye Enucleation for Remote High-throughput Phenotyping
05:30

Mouse Eye Enucleation for Remote High-throughput Phenotyping

Published on: November 19, 2011

21.2K

[Genome Editing Tools and their Application in Experimental Ophthalmology].

M Yanik1, W Wende2, K Stieger1

  • 1Klinik und Poliklinik für Augenheilkunde, Justus-Liebig-Universität Gießen, Fachbereich Medizin.

Klinische Monatsblatter Fur Augenheilkunde
|January 24, 2017
PubMed
Summary
This summary is machine-generated.

New genome editing tools like CRISPR/Cas enable precise gene surgery. These advancements are revolutionizing experimental ophthalmology, focusing on retinal disease treatments through in vivo gene editing.

More Related Videos

Improved Genome Editing via Oviductal Nucleic Acids Delivery-based In Vivo Electroporation Technique for Knockout Mice Generation
09:56

Improved Genome Editing via Oviductal Nucleic Acids Delivery-based In Vivo Electroporation Technique for Knockout Mice Generation

Published on: August 26, 2025

716
Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research
10:10

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Published on: November 2, 2018

9.9K

Related Experiment Videos

Last Updated: Mar 8, 2026

Mouse Eye Enucleation for Remote High-throughput Phenotyping
05:30

Mouse Eye Enucleation for Remote High-throughput Phenotyping

Published on: November 19, 2011

21.2K
Improved Genome Editing via Oviductal Nucleic Acids Delivery-based In Vivo Electroporation Technique for Knockout Mice Generation
09:56

Improved Genome Editing via Oviductal Nucleic Acids Delivery-based In Vivo Electroporation Technique for Knockout Mice Generation

Published on: August 26, 2025

716
Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research
10:10

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Published on: November 2, 2018

9.9K

Area of Science:

  • Molecular Biology
  • Genetics
  • Ophthalmology

Background:

  • Genome editing tools, including zinc-finger nucleases (ZFN), transcription activator-like effector nucleases (TALEN), and CRISPR/Cas systems, offer precise DNA cleavage.
  • DNA double-strand breaks are repaired via non-homologous end joining (NHEJ) and homology-directed repair (HDR).

Purpose of the Study:

  • To explore the revolutionary impact of genome editing technologies on molecular biology and experimental ophthalmology.
  • To highlight the potential of gene editing for therapeutic strategies targeting retinal diseases.

Main Methods:

  • Utilizing CRISPR/Cas systems for site-specific DNA cleavage in living cells.
  • Employing NHEJ and HDR repair pathways with DNA templates to correct gene defects or mutations.

Main Results:

  • CRISPR/Cas systems demonstrate high efficiency in site-specific DNA cleavage.
  • Genome editing facilitates gene knockout and mutation repair through cellular repair pathways.

Conclusions:

  • Genome editing technologies provide new strategies for basic, biotechnological, and biomedical sciences.
  • The eye's accessibility makes retinal diseases a primary focus for in vivo therapeutic gene editing.